Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SHE:002693)
7.89
+0.14 (1.81%)
Feb 4, 2026, 3:04 PM CST
SHE:002693 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 28.7 | 45.11 | 3.39 | 12.2 | 21.62 | 5.8 |
Trading Asset Securities | 26.22 | 0 | 28.52 | 133.81 | 55.4 | 94.25 |
Cash & Short-Term Investments | 54.92 | 45.11 | 31.9 | 146.01 | 77.02 | 100.05 |
Cash Growth | 9.29% | 41.39% | -78.15% | 89.57% | -23.02% | 4.79% |
Accounts Receivable | 24.52 | 15.17 | 16.36 | 28.13 | 20.77 | 24.94 |
Other Receivables | 11.53 | 11.39 | 11.74 | 11.58 | 11.85 | 11.97 |
Receivables | 36.05 | 26.56 | 28.1 | 39.71 | 32.62 | 36.91 |
Inventory | 85.66 | 80.54 | 74.31 | 65.41 | 55.24 | 52.79 |
Other Current Assets | 2.19 | 3.76 | 0.93 | 1.26 | 0.57 | 7.75 |
Total Current Assets | 178.82 | 155.97 | 135.24 | 252.39 | 165.45 | 197.5 |
Property, Plant & Equipment | 397.1 | 420.62 | 457.6 | 471.77 | 504.73 | 541 |
Long-Term Investments | - | - | 10 | - | - | - |
Other Intangible Assets | 106.39 | 57.92 | 52.81 | 72.09 | 78.82 | 64.46 |
Long-Term Deferred Tax Assets | 1.07 | 1 | 1.52 | 0.97 | 1.03 | 0.66 |
Long-Term Deferred Charges | 84.97 | 124.25 | 124.22 | 96.3 | 80.14 | 72.4 |
Other Long-Term Assets | 29.41 | 24.1 | 21.87 | 17.5 | 24.38 | 31.65 |
Total Assets | 797.77 | 783.87 | 803.25 | 911.02 | 854.56 | 907.68 |
Accounts Payable | 23.55 | 21.09 | 17.14 | 15.5 | 17.16 | 15.44 |
Accrued Expenses | 9.69 | 16.38 | 24.52 | 36.35 | 40.61 | 32.78 |
Short-Term Debt | 75.22 | 63.45 | 41 | 18.06 | 10.45 | 55.41 |
Current Portion of Long-Term Debt | 39.21 | 28.26 | 10.05 | 205.3 | 0.25 | - |
Current Income Taxes Payable | 5.07 | - | - | - | - | - |
Current Unearned Revenue | 51.05 | 38.78 | 31.88 | 23.53 | 12.35 | 9.5 |
Other Current Liabilities | 3.4 | 9.02 | 15.36 | 20.62 | 27.59 | 16.28 |
Total Current Liabilities | 207.19 | 176.99 | 139.94 | 319.36 | 108.41 | 129.41 |
Long-Term Debt | 176.5 | 184.5 | 135 | - | 167 | 167 |
Long-Term Unearned Revenue | 7.72 | 8.56 | 8.03 | 7.64 | 8.87 | 10.25 |
Long-Term Deferred Tax Liabilities | 2.02 | 2.21 | 2.63 | 3.08 | 3.53 | 2.7 |
Total Liabilities | 393.42 | 372.26 | 285.6 | 330.08 | 287.8 | 309.37 |
Common Stock | 414.69 | 414.69 | 416.73 | 414.74 | 412 | 405 |
Additional Paid-In Capital | 369.91 | 369.91 | 371.65 | 368.98 | 354.38 | 338.77 |
Retained Earnings | -393.36 | -390.84 | -312.53 | -261.79 | -270.8 | -250.48 |
Treasury Stock | - | - | -4.01 | -8.02 | -13.37 | - |
Comprehensive Income & Other | -0.35 | -0.35 | -0.35 | -0.36 | -0.36 | -0.37 |
Total Common Equity | 390.89 | 393.41 | 471.49 | 513.55 | 481.85 | 492.93 |
Minority Interest | 13.45 | 18.2 | 46.16 | 67.39 | 84.9 | 105.39 |
Shareholders' Equity | 404.35 | 411.61 | 517.65 | 580.94 | 566.75 | 598.31 |
Total Liabilities & Equity | 797.77 | 783.87 | 803.25 | 911.02 | 854.56 | 907.68 |
Total Debt | 290.93 | 276.21 | 186.05 | 223.36 | 177.7 | 222.41 |
Net Cash (Debt) | -236.01 | -231.1 | -154.15 | -77.35 | -100.67 | -122.36 |
Net Cash Per Share | -0.57 | -0.56 | -0.36 | -0.17 | -0.25 | -0.30 |
Filing Date Shares Outstanding | 414.69 | 414.69 | 416.73 | 414.74 | 412 | 405 |
Total Common Shares Outstanding | 414.69 | 414.69 | 416.73 | 414.74 | 412 | 405 |
Working Capital | -28.37 | -21.02 | -4.71 | -66.97 | 57.04 | 68.09 |
Book Value Per Share | 0.94 | 0.95 | 1.13 | 1.24 | 1.17 | 1.22 |
Tangible Book Value | 284.5 | 335.49 | 418.68 | 441.46 | 403.03 | 428.46 |
Tangible Book Value Per Share | 0.69 | 0.81 | 1.00 | 1.06 | 0.98 | 1.06 |
Buildings | - | 388.73 | 388.5 | 388.67 | 388.28 | 382.71 |
Machinery | - | 441.57 | 435.36 | 418.58 | 406.11 | 398.91 |
Construction In Progress | - | 16.99 | 18 | 4.14 | 3.02 | 6.38 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.